Hot Natural Products & Bioactive Compounds
BioCrick offers high-purity natural products and bioactive compounds for scientific research. Our natural product collection includes compounds derived from plants, microorganisms and other biological sources and is widely used in pharmacological, biochemical and drug discovery research.
Natural products remain an important source of bioactive molecules and drug leads. BioCrick provides researchers with high-quality natural product compounds together with catalog numbers, product information and biological activity data.
Hot Products from BioCrick
Showing 5257 - 5264 of 9359 hot products
| Catalog No. | Product Name |
|---|---|
| BCN3322 | Lobetyolinin |
|
1. Lobetyolinin exhibits DPPH radical scavenging activity.
|
|
| BCN3323 | Deacetylasperulosidic acid |
|
1. Deacetylasperulosidic acid may increase catalase activity.
2. Deacetylasperulosidic acid inhibits the reduction of ear swelling, and also cancels the suppression of IL-2 production along with the activation of natural killer cells in the same manner as that of Noni-ext. |
|
| BCN3324 | Chrysin 6-C-glucoside |
|
Standard reference
|
|
| BCN3325 | Baicalein 6-O-glucoside |
|
Baicalein 6-O-glucoside is a natural product from Thymus serpyllum L.
|
|
| BCN3326 | 5-Methoxycanthin-6-one |
|
1. 5-Methoxycanthin-6-one exhibits a clear suppressive effect on the phagocytosis response upon activation with serum-opsonized zymosan in the range of IC₅₀ = 0.9-2.0 uM versus ibuprofen with IC₅₀ = 12.1 uM.
2. 5-Methoxycanthin-6-one displays moderate cytotoxic activity against the human prostate cancer cell PC-3 line, with IC₅₀ values ranging from 13.5-15.4 uM versus doxorubicine with IC₅₀ = 1.5 uM. |
|
| BCN3327 | Didymin |
|
Didymin is a citrus-derived natural compound that kills p53 wild-type as well as drug-resistant p53-mutant neuroblastoma cells in culture, it induces apoptosis by inhibiting N-Myc and upregulating RKIP in neuroblastoma. Didymin possesses antioxidant, anti-inflammation and anti-cancer properties.
|
|
| BCN3328 | Notoginsenoside R2 |
|
1. Notoginsenoside R2 has neuroprotection against 6-OHDA-induced neurotoxicity, is associated with Notoginsenoside R2-mediated P90RSK and Nrf2 activation through MEK1/2-ERK1/2 pathways.
|
|
| BCN3329 | 3beta-Hydroxylanosta-8,24-diene-21-al |
|
3beta-Hydroxylanosta-8,24-diene-21-al may have cancer cell growth inhibitory activity against P388, HL-60, L1210 and KB cell lines.
|
|